Regensburg, July 12, 2007. Today, GENEART AG announces the acquisition of US patent 6472184 "Method for Producing Nucleic Acid Polymers". The patent-protected technology is used for the synthesis of complex gene sequences. The rights to this patent are a suitable fit to complement the GENEART patent portfolio. The seamless coverage of the production process is an important competitive advantage for GENEART in the collaboration with large customers in the pharmaceutical and chemical industry as well as in the biotechnology field.
